Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jing-Feng Liu

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Oxidative Medicine and Cellular Longevity|June 1, 2018
Partial Inhibition of HO-1 Attenuates HMP-Induced Hepatic Regeneration against Liver Injury in RatsNing He, Jun-Jun Jia, Hai-Yang Xie, et al.
Ebiomedicine|September 12, 2024
Establishment and validation of circulating cell-free DNA signatures for nasopharyngeal carcinoma detectionSu-Fang Qiu, Qing-Zheng Zhang, Zi-Yi Wu, et al.
Theranostics|July 9, 2019
Circular RNAs negatively regulate cancer stem cells by physically binding FMRP against CCAR1 complex in hepatocellular carcinomaYan-Jing Zhu, Bo Zheng, Gui-Juan Luo, et al.
Gastroenterology|January 10, 2017
Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor ProgressionXi-Meng Lin, Liang Hu, Jin Gu, et al.
Cancer Management and Research|June 27, 2019
Development and validation of a prognostic score predicting recurrence in resected combined hepatocellular cholangiocarcinomaMeng-Xin Tian, Liu-Ping Luo, Wei-Ren Liu, et al.
Cancer Letters|May 22, 2016
Lipopolysaccharide supports maintaining the stemness of CD133(+) hepatoma cells through activation of the NF-κB/HIF-1α pathwayFo-Bao Lai, Wen-Ting Liu, Ying-Ying Jing, et al.
Theranostics|May 7, 2020
Targeted sequencing reveals the mutational landscape responsible for sorafenib therapy in advanced hepatocellular carcinomaJing Tang, Cheng-Jun Sui, Dong-Fang Wang, et al.
Journal of Hepatology|January 18, 2019
A novel HBx genotype serves as a preoperative predictor and fails to activate the JAK1/STATs pathway in hepatocellular carcinomaQing-Guo Xu, Sheng-Xian Yuan, Qi-Fei Tao, et al.
Journal of Clinical and Translational Hepatology|September 15, 2025
Hepatocellular Carcinoma Risk Stratification for Cirrhosis Patients: Integrating Radiomics and Deep Learning Computed Tomography Signatures of the Liver and Spleen into a Clinical ModelRong Fan, Ya-Ru Shi, Lei Chen, et al.
Gut|May 27, 2018
Effect of Huaier granule on recurrence after curative resection of HCC: a multicentre, randomised clinical trialQian Chen, Chang Shu, Arian D Laurence, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Oxidative Medicine and Cellular Longevity|June 1, 2018
Partial Inhibition of HO-1 Attenuates HMP-Induced Hepatic Regeneration against Liver Injury in RatsNing He, Jun-Jun Jia, Hai-Yang Xie, et al.
Ebiomedicine|September 12, 2024
Establishment and validation of circulating cell-free DNA signatures for nasopharyngeal carcinoma detectionSu-Fang Qiu, Qing-Zheng Zhang, Zi-Yi Wu, et al.
Theranostics|July 9, 2019
Circular RNAs negatively regulate cancer stem cells by physically binding FMRP against CCAR1 complex in hepatocellular carcinomaYan-Jing Zhu, Bo Zheng, Gui-Juan Luo, et al.
Gastroenterology|January 10, 2017
Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor ProgressionXi-Meng Lin, Liang Hu, Jin Gu, et al.
Cancer Management and Research|June 27, 2019
Development and validation of a prognostic score predicting recurrence in resected combined hepatocellular cholangiocarcinomaMeng-Xin Tian, Liu-Ping Luo, Wei-Ren Liu, et al.
Cancer Letters|May 22, 2016
Lipopolysaccharide supports maintaining the stemness of CD133(+) hepatoma cells through activation of the NF-κB/HIF-1α pathwayFo-Bao Lai, Wen-Ting Liu, Ying-Ying Jing, et al.
Theranostics|May 7, 2020
Targeted sequencing reveals the mutational landscape responsible for sorafenib therapy in advanced hepatocellular carcinomaJing Tang, Cheng-Jun Sui, Dong-Fang Wang, et al.
Journal of Hepatology|January 18, 2019
A novel HBx genotype serves as a preoperative predictor and fails to activate the JAK1/STATs pathway in hepatocellular carcinomaQing-Guo Xu, Sheng-Xian Yuan, Qi-Fei Tao, et al.
Journal of Clinical and Translational Hepatology|September 15, 2025
Hepatocellular Carcinoma Risk Stratification for Cirrhosis Patients: Integrating Radiomics and Deep Learning Computed Tomography Signatures of the Liver and Spleen into a Clinical ModelRong Fan, Ya-Ru Shi, Lei Chen, et al.
Gut|May 27, 2018
Effect of Huaier granule on recurrence after curative resection of HCC: a multicentre, randomised clinical trialQian Chen, Chang Shu, Arian D Laurence, et al.
Pageof 6